Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marie Frimat

Showing results (1-10 of 63) with videos related to

Pageof 7
Sort By:
Clinical Journal of the American Society of Nephrology : CJASN|June 10, 2026
Complement Genetics in IgA Nephropathy: From Biological Plausibility to Tailored Therapy?Marie Frimat, Giliane Nanchen, Fadi Fakhouri
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 24, 2016
In Reply to 'Risk of Tranexamic Acid for Treatment of Postpartum Hemorrhage'Marie Frimat, François Provôt, Alexandre Hertig
Aging|September 9, 2019
Is RAGE the receptor for inflammaging?Marie Frimat, Thibault Teissier, Eric Boulanger
International Journal of Molecular Sciences|March 6, 2021
Heme Oxygenase 1: A Defensive Mediator in Kidney DiseasesAnne Grunenwald, Lubka T Roumenina, Marie Frimat
Toxins|November 27, 2019
Hemolysis Derived Products Toxicity and Endothelium: Model of the Second HitMarie Frimat, Idris Boudhabhay, Lubka T Roumenina
Journal of the American Society of Nephrology : JASN|October 16, 2024
Toward a Restrictive Use of Plasma Exchanges in Thrombotic MicroangiopathiesMarie Frimat, Nora Schwotzer, François Provôt, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 18, 2025
Do we still need plasma exchanges for thrombotic microangiopathies? NoFadi Fakhouri, Eva Jenny, François Provôt, et al.
Kidney International Reports|June 20, 2024
Letter to the editor about: "Eculizumab First" in the Management of Posttransplant Thrombotic MicroangiopathySimon Ville, Leo Drapeau, Jean Paraire, et al.
Frontiers in Medicine|March 13, 2024
Pregnancy as a susceptible state for thrombotic microangiopathiesMarie Frimat, Viviane Gnemmi, Morgane Stichelbout, et al.
Immunological Reviews|October 27, 2016
Endothelial cells: source, barrier, and target of defensive mediatorsLubka T Roumenina, Julie Rayes, Marie Frimat, et al.
Pageof 7

Showing results (1-10 of 63) with videos related to

Sort By:
Pageof 7
Clinical Journal of the American Society of Nephrology : CJASN|June 10, 2026
Complement Genetics in IgA Nephropathy: From Biological Plausibility to Tailored Therapy?Marie Frimat, Giliane Nanchen, Fadi Fakhouri
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 24, 2016
In Reply to 'Risk of Tranexamic Acid for Treatment of Postpartum Hemorrhage'Marie Frimat, François Provôt, Alexandre Hertig
Aging|September 9, 2019
Is RAGE the receptor for inflammaging?Marie Frimat, Thibault Teissier, Eric Boulanger
International Journal of Molecular Sciences|March 6, 2021
Heme Oxygenase 1: A Defensive Mediator in Kidney DiseasesAnne Grunenwald, Lubka T Roumenina, Marie Frimat
Toxins|November 27, 2019
Hemolysis Derived Products Toxicity and Endothelium: Model of the Second HitMarie Frimat, Idris Boudhabhay, Lubka T Roumenina
Journal of the American Society of Nephrology : JASN|October 16, 2024
Toward a Restrictive Use of Plasma Exchanges in Thrombotic MicroangiopathiesMarie Frimat, Nora Schwotzer, François Provôt, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 18, 2025
Do we still need plasma exchanges for thrombotic microangiopathies? NoFadi Fakhouri, Eva Jenny, François Provôt, et al.
Kidney International Reports|June 20, 2024
Letter to the editor about: "Eculizumab First" in the Management of Posttransplant Thrombotic MicroangiopathySimon Ville, Leo Drapeau, Jean Paraire, et al.
Frontiers in Medicine|March 13, 2024
Pregnancy as a susceptible state for thrombotic microangiopathiesMarie Frimat, Viviane Gnemmi, Morgane Stichelbout, et al.
Immunological Reviews|October 27, 2016
Endothelial cells: source, barrier, and target of defensive mediatorsLubka T Roumenina, Julie Rayes, Marie Frimat, et al.
Pageof 7